Figure 7 | Scientific Reports

Figure 7

From: Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma

Figure 7

Molecular docking of core target gene TP53, IL6, and VEGFA with 4 main ingredients of SS respectively. (A) isobrucine-TP53, (B) stigmasterol-TP53, (C) (+)-catechin-TP53, (D) brucine-TP53, (E) isobrucine-IL6, (F) stigmasterol-IL6, (G) (+)-catechin-IL6, (H) brucine-IL6, (I) isobrucine-VEGFA, (J) stigmasterol-VEGFA, (K) (+)-catechin-VEGFA, (L) brucine-VEGFA.

Back to article page